Auditing the transparency policies of pharma

11:39 EDT 28 Jul 2017 | British Medical Journal

If you’ve listened to more than one of our podcasts, you’ll probably be aware of the problem of the opacity of clinical trial data - trials which are conducted by never see the light of day, or results within those trials which are never published. Pharmaceutical companies have their own policies on what they are willing to make public, when, and...

Original Article: Auditing the transparency policies of pharma


More From BioPortfolio on "Auditing the transparency policies of pharma"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...